LMG Life Sciences | Page 5

Contents FEATURED CONTENT Industry Profile: Genentech’s Mark Jackson The Impact of the First to File Statute on Life Sciences LMG LIFE SCIENCES 2013 5 5 7 REGULATORY A Q&A with Coleen Klasmeier and Gail Javitt, Sidley Austin FDA Efforts to Balance Health IT Innovation and Safety Supplier Quality – The New Frontier in Drug Manufacture Imperative: Comparative Effectiveness Research League tables Firm briefings Attorney listings 9 9 12 15 18 22 23 28 INTELLECTUAL PROPERTY The Decision: Gene Patentability Supreme Court Rejection of ‘Scope o f the Patent’ Test League tables Firm briefings Attorney listings Biographies and Firm Profiles 33 33 35 38 40 53 67 FINANCE & TRANSACTIONAL Academics Lead the Way for Industry Research League tables Firm briefings Attorney listings 85 85 87 89 96 NON-IP LITIGATION AND ENFORCEMENT Top 10 Guidelines for Life Sciences Companies in 2013 League tables Firm briefings Attorney listings Biographies and Firm Profiles 101 101 103 104 114 124 LIFE CYCLE FIRMS Arnold & Porter Covington & Burling Goodwin Procter Hogan Lovells Latham & Watkins Morgan Lewis & Bockius Morrison & Foerster Ropes & Gray Sidley Austin WilmerHale Biographies and Firm Profiles 129 129 130 131 132 133 134 135 136 137 138 139 CANADA The Same But Different: Patent Linkage in Canada League tables Firm briefings Attorney listings Biographies 153 153 155 157 164 168 INDEX OF FIRMS 175 LMG LIFE SCIENCES 2013 3